Rang	Name	Position
1	Mr. Joshua Riggs	President, CEO & Director
2	Ms. Andrea Susan James	Chief Financial Officer
3	Mr. James Liu	VP of Accounting, Treasurer, Controller & Principal Accounting Officer
4	Dr. Ekkehard Schutz M.D., Ph.D.	Chief Science Officer
5	Mr. Yuh-Min Chiang Ph.D.	Chief Technology Officer
6	Mr. Peter Hong	VP, General Counsel & Secretary
7	Ms. Sandra O'Donald	Senior Vice President of Business Operations
8	Dr. Paul R. Billings FACP, M.D.	Consulting Chief Medical Officer
9	Dr. Michael D. West Ph.D.	Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc.
10	Ms. Gabrielle Woody	Sr. Executive Assistant

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BROADWOOD CAPITAL Inc	39,87%	36,49 Mio. USD
2	Awm Investment Company Inc	9,86%	9,03 Mio. USD
3	Vanguard Group Inc	1,69%	1,55 Mio. USD
4	Geode Capital Management, LLC	0,56%	0,51 Mio. USD
5	BlackRock Inc	0,28%	0,26 Mio. USD
6	Morgan Stanley - Brokerage Accounts	0,22%	0,20 Mio. USD
7	Citadel Advisors Llc	0,17%	0,16 Mio. USD
8	Susquehanna International Group, LLP	0,16%	0,14 Mio. USD
9	FNY Investment Advisers, LLC	0,14%	0,13 Mio. USD
10	Defender Capital, LLC.	0,12%	0,11 Mio. USD
11	Northern Trust Corp	0,10%	0,09 Mio. USD
12	State Street Corp	0,07%	0,06 Mio. USD
13	PURA VIDA INVESTMENTS, LLC	0,07%	0,06 Mio. USD
14	SG Americas Securities, LLC	0,06%	0,05 Mio. USD
15	Millennium Management LLC	0,05%	0,04 Mio. USD
16	HRT FINANCIAL LLC	0,04%	0,03 Mio. USD
17	UBS Group AG	0,01%	0,01 Mio. USD
18	Advisor Group Holdings, Inc.	0,00%	0,00 Mio. USD
19	Tower Research Capital LLC	0,00%	0,00 Mio. USD
20	ORG Partners LLC	0,00%	0,00 Mio. USD